Russ Altman (Stanford University) & Kim Branson (GSK) - Principled Engineering: AI and Drug Development
Entrepreneurial Thought Leaders (ETL)
00:00
Is a I a Good Drug Discovery Tool?
There's always a lot of hipe in the media about the use of a i an drug discovery and development. What are the areas where a i and m l does and does not work? Is the way they pfort or let's say, where is it more promising? Where is it potentially overhiped?" Andim trying to t do many of the audience questions, is possible? I still have a few that will probably get to. But on the other side, but from the audience, there's always a much bigger question: How can we make drugs out of big data? We're now building models that look on open and closed chromatograms which explain how things can change
Play episode from 42:27
Transcript
